Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.20
Ask: 1.30
Change: -0.15 (-10.71%)
Spread: 0.10 (8.333%)
Open: 1.40
High: 1.40
Low: 1.25
Prev. Close: 1.40
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

Fri, 03rd May 2024 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Fletcher King PLC, up 26% at 44.00 pence, 12-month range 31.00p-49.00p. It reports a "strong second half business performance", a turnaround from the more "cautionary business outlook" it gave back in December. Revenue for the year ended April 30 "is now expected to be materially higher than management expectations". Pretax profit is expected to be between two and three times higher than the GBP192,000 it reported for the prior year.

----------

Angle PLC, up 11% at 15.20 pence, 12-month range 9.07p-37.40p. The firm strikes a deal with AstraZeneca to develop a "Parsortix-based androgen receptor" detection assay to be used in prostate cancer studies. Medical diagnostics provider Angle says the deal is worth GBP550,000.

----------

AIM - LOSERS

----------

Physiomics PLC, down 16% at 1.26p, 12-month range 0.90p-3.29p. The data science company, focused on new therapeutics and personalised medicine solutions, warns several large contracts have taken longer than expected to be signed. It predicts total income for the year to June 30 will decline to a range of GBP600,000-GBP650,000 as a result. It adds: "The company is in the final stages of negotiation for two projects (one with an existing client and one with a potential new client), the total value of which is expected to be, in aggregate, approximately GBP350,000. Whilst the board anticipates that the contracts for these two projects will be signed in FY24, the majority of the revenue is now expected be recognised in the company's next financial year ending 30 June 2025, and accordingly the board's expectations for FY25 revenues have been correspondingly increased. "

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
30 Sep 2021 15:45

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

Read more
23 Sep 2021 15:59

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Sep 2021 20:36

IN BRIEF: Physiomics recruits first patient for Partner study

IN BRIEF: Physiomics recruits first patient for Partner study

Read more
21 May 2021 17:51

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

Read more
21 May 2021 11:48

AIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash

AIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash

Read more
21 May 2021 09:53

Physiomics inks further contracts with Bicycle Therapeutics

(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.

Read more
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:27

Physiomics secures follow-on contract from Merck KgaA

Physiomics secures follow-on contract from Merck KgaA

Read more
14 May 2021 08:27

Physiomics secures additional contract with Merck

(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.

Read more
11 May 2021 17:50

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Read more
11 May 2021 10:46

Physiomics secures contract with Numab Therapeutics

(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.

Read more
10 May 2021 10:21

Physiomics says full-year results to disappoint market forecasts

Physiomics says full-year results to disappoint market forecasts

Read more
10 May 2021 10:19

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

Read more
10 May 2021 08:40

Physiomics FY income likely to fall short of market expectations

(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.

Read more
1 Mar 2021 11:29

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.